Digital health case studyPharmaceutical
Prioritising Markets and Partners to Accelerate a Women’s Health Roadmap
Client context: Global pharma, women’s health franchise
Strategic question
Which priority markets and venture partners should anchor our future women’s health innovation roadmap, starting with telemedicine?
Decision enabled
What the client could do next
Enabled the franchise to sequence market entry and focus partnership investment on a prioritised shortlist of ventures.
Approach
Powered by HealthTech Alpha, we evaluated ecosystem maturity across five priority markets, assessed patient cohorts, therapeutic mix and bio-pharma partnership activity, and ran structured scouting with expert interviews to validate business models.
Methodology
Strategic interpretation
Surfaced where women’s health innovation was most defensible to scale and where telemedicine could be adopted first, clarifying market-level white space.
